PARATEK PHARMACEUTICALS INC - NOTE 4.750% 5/0

Historical Holders from Q2 2019 to Q4 2023

Type / Class
Debt / NOTE 4.750% 5/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PARATEK PHARMACEUTICALS INC - NOTE 4.750% 5/0 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2023 Q4 $0 $0 -$39,252,518 0
2023 Q3 $38,738,000 $39,252,518 -$67,422,095 100.5% 3
2023 Q2 $121,856,986 $123,777,766 -$4,341,142 97.92% 18
2023 Q1 $115,625,421 $91,713,765 +$14,776,541 74.96% 19
2022 Q4 $95,270,000 $85,547,096 -$21,865,545 87.5% 19
2022 Q3 $124,177,000 $110,191,485 +$4,929,001 88.53% 19
2022 Q2 $118,906,000 $104,197,000 +$27,132,511 85.46% 18
2022 Q1 $86,835,000 $77,320,000 -$23,009,434 88.53% 17
2021 Q4 $111,758,000 $102,036,000 +$1,515,351 91.5% 16
2021 Q3 $113,862,000 $99,777,000 +$138,838 88.27% 17
2021 Q2 $113,630,000 $105,462,000 +$10,670,449 92.46% 17
2021 Q1 $122,105,000 $114,289,000 +$1,705,455 90.29% 14
2020 Q4 $100,215,000 $87,388,000 +$10,735,435 86.83% 16
2020 Q3 $87,579,119 $71,941,000 -$1,689,835 82.2% 12
2020 Q2 $89,469,000 $68,481,000 -$4,741,574 80.67% 11
2020 Q1 $115,650,000 $90,610,000 -$7,872,616 71.8% 13
2019 Q4 $121,568,000 $90,753,000 -$9,474,653 71.73% 14
2019 Q3 $131,818,000 $93,689,000 +$1,449,983 72.29% 16
2019 Q2 $131,395,000 $91,099,000 +$91,098,820 68.25% 17